Home
Products
About
Research
Business
Partners
News
Contact Us
Home
News
Circadin® receives marketing authorization in Peru
Circadin® receives marketing authorization in Peru
More news:
Next: Circadin® 2mg (prolonged-release melatonin) is now commercially available in Colombia
Previous: Vigisom® 2mg (prolonged-release melatonin) is now commercially available in Chile
Text size:
A
A
A
Recent news
Slenyto (PedPRM) is now available in Norway!
Neurim Pharmaceuticals attends the ESCAP Congress in Vienna, Austria, 30 June – 2 July 2019
Slenyto (PedPRM) is now also available in Italy!
Partners
Home
Products
Circadin®
Insomnia
Chronic Insomnia
Ask a Question
Piromelatine
About
Founders
Career
Research
Therapeutic Area
Business
Partners
News
Contact Us